Your browser doesn't support javascript.
loading
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
Capriotti, Kara D; Anadkat, Milan; Choi, Jennifer; Kaffenberger, Benjamin; McLellan, Beth; Barone, Samuel; Kukoyi, Oluwaseun; Goldfarb, Shari; Lacouture, Mario.
Afiliação
  • Capriotti KD; Veloce BioPharma LLC, Fort Lauderdale, FL, USA. kcapriotti@velocebiopharma.com.
  • Anadkat M; Bryn Mawr Skin and Cancer Institute, 919 Conestoga Road, Building 2, Suite 106, Rosemont, PA, 19010, USA. kcapriotti@velocebiopharma.com.
  • Choi J; Department of Medicine, Division of Dermatology, Washington University School of Medicine, Saint Louis, MO, USA.
  • Kaffenberger B; Department of Dermatology, Ohio State University Dermatology, Columbus, OH, USA.
  • McLellan B; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Barone S; Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Kukoyi O; Veloce BioPharma LLC, Fort Lauderdale, FL, USA.
  • Goldfarb S; Department of Medicine, Dermatology Service, New York, NY, USA.
  • Lacouture M; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Invest New Drugs ; 37(6): 1247-1256, 2019 12.
Article em En | MEDLINE | ID: mdl-31240513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroniquia / Povidona-Iodo / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroniquia / Povidona-Iodo / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article